Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Lecube, Albert ^a   Sampol, Gabriel ^b   Lloberes, Patricia ^b   Romero, Odile ^c   Mesa, Jordi ^a   Hernández, Cristina ^a   Simó, Rafael ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LUNG FUNCTION TEST; MALE; MULTICHANNEL RECORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXYGEN SATURATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SLEEP APNEA SYNDROME; SMOKING HABIT; TOTAL LUNG CAPACITY; WAIST CIRCUMFERENCE; ANOXIA; CASE CONTROL STUDY; DIABETES MELLITUS;

ANOXIA; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; OBESITY; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 61849115153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004692     Document Type: Article

References (25)

1. Marin JM, Carrizo SJ, Vicente E, Agustí AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053.
2. Young T, Peppard PE, Taheri S (2005) Excess weight and sleep-disordered breathing. J Appl Physiol 99: 1592-1599.
3. Tasali E, Mokhlesi B, Van Cauter E (2008) Obstructive sleep apnea and type 2 diabetes. Interacting epidemics. Chest 133: 496-506.
4. Peltier AC, Consens FB, Sheikh K, Wang L, Song Y, et al. (2007) Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med 8: 149-155.
5. Punjabi NM, Polotsky VY (2005) Disorders of glucose metabolism in sleep apnea. J Appl Physiol 99: 1998-2007.
6. Vgontzas A, Legro R, Bixler E, Grayev A, Kales A, et al. (2001) Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 86: 517-520.
7. Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, et al. (2003) Sleep Heart Health Study: Diabetes and sleep disturbances: findings from the Sleep Heart health Study. Diabetes Care 26: 702-709.
8. Ramadan W, Dewasmes G, Petitjean M, Wiernsperger N, Delanaud S, et al. (2007) Sleep apnea is induced by a high-fat diet and reversed and prevented by metformin in non-obese rats. Obesity (Silver Spring) 15: 1409-1418.
9. American Diabetes Association (2005) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 28: S37-S42.
10. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14: 540-545.
11. Lloberes P, Sampol G, Levy G, Aristizabal D, Sagales T, et al. (2001) Influence of setting on unattended respiratory monitoring in the sleep apnoea-hypopnoea syndrome. Eur Respir J 16: 530-534.
12. Quanjer PH, Tammeling GJ, Cotes LE, Pedersen OF, Peslin R, et al. (1996) Lung volumes and forced ventilatory flows. Eur Respir J 16 (suppl): 41-52.
13. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, et al. (1986) Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22: 217-224.
14. Lavie L (2003) Obstructive sleep apnoea syndrome. An oxidative stress disorder. Sleep Med Rev 7: 35-51.
15. Hartge MM, Unger T, Kintscher U (2007) The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res 4: 84-88.
16. Bradley TD, Martinez D, Rutherford R, Lue F, Grossman RF, et al. (1985) Physiological determinants of nocturnal arterial oxygenation in patients with obstructive sleep apnea. J Appl Physiol 59: 1364-1368.
17. Williams S, Scharf SM (2007) Obstructive sleep apnea, cardiovascular disease, and inflammation-is NF-kappa B the key? Sleep Breath 11: 69-76.
18. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, et al. (2004) Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-α antagonist. J Clin Endocrinol Metab 89: 4409-4413.
19. Ficker JH, Dertinger SH, Siegfried W, König HJ, Pentz M, et al. (1998) Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 11: 14-19.
20. Bottini P, Dottorini ML, Cristina Cordomi M, Casucci G, Tantucci C (2003) Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 22: 654-660.
21. Campo A, Frühbeck G, Zulueta JJ, Iriarte J, Seijo LM, et al. (2007) Hyperleptinemia, respiratory drive and hypercapnia response in obese patients. Eur Respir J 30: 223-231.
22. Hein MS, Schlenker EH, Patel KP (1994) Altered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med 207: 213-219.
23. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM (2004) Fremantle Diabetes Study: Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Study. Diabetes Care 27: 752-757.
24. Guazzi M, Oreglia I, Guazzi MD (2002) Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes. Diabetes Care 25: 1802-1806.
25. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, et al. (1997) Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 241: 11-18.